Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

PLATINUM
FDA Approves Unknown Drug — PLATINUM

PLATINUM announced the FDA approval of their ANDA submission, though specific product details and market implications are unavailable. Without a defin...

ZYDUS
FDA Approves Unknown Drug — ZYDUS PHARMS

ZYDUS PHARMS has received FDA approval for an ANDA (ANDA206097), a move that strengthens its commercial portfolio and is expected to create a signific...

Bausch
FDA Approves SILIQ — Bausch Health US LLC

Bausch Health US LLC secured FDA approval for the subcutaneous formulation of Brodalumab under the brand SILIQ, a move expected to significantly diver...

Chattem,
FDA Approves XYZAL ALLERGY 24HR — Chattem, Inc.

# FDA Approves Chattem's XYZAL ALLERGY 24HR for Over-the-Counter Use The FDA has approved Chattem, Inc.'s levocetirizine dihydrochloride formulation ...

Chattem,
FDA Approves CHILDRENS XYZAL ALLERGY — Chattem, Inc.

# FDA Approves Chattem's Children's Xyzal Allergy Formulation Chattem, Inc. received FDA approval for Children's Xyzal Allergy (levocetirizine dihydr...

Zydus
FDA Approves METHOTREXATE — Zydus Pharmaceuticals USA Inc.

Zydus Pharmaceuticals USA Inc. received FDA approval for oral Methotrexate under ANDA207812, marking a potential new generic entry into a crowded mark...

Saptalis
FDA Approves DESOXIMETASONE — Saptalis Pharmaceuticals, LLC.

# FDA Approves Saptalis Pharmaceuticals' Generic Desoximetasone Topical Treatment Saptalis Pharmaceuticals, LLC received FDA approval for its generic...

Biogen
FDA Approves SPINRAZA — Biogen Inc.

# FDA Approves Biogen's SPINRAZA for Spinal Muscular Atrophy, Opening Rare Disease Market Opportunity Biogen Inc. received FDA approval for SPINRAZA ...

UNICHEM
FDA Approves METFORMIN HYDROCHLORIDE — UNICHEM PHARMACEUTICALS (USA), INC.

UNICHEM PHARMACEUTICALS (USA), INC. has secured FDA approval for its preferred ANDA 207427 to manufacture generic metformin hydrochloride tablets, a m...

Boehringer
FDA Approves SYNJARDY XR — Boehringer Ingelheim Pharmaceuticals, Inc.

Boehringer Ingelheim today announced the FDA approval of SYNJARDY XR Empagliflozin/Metformin Hydrochloride, an extended-release oral tablet designed t...

Macleods
FDA Approves METFORMIN HYDROCHLORIDE — Macleods Pharmaceuticals Limited

Macleods Pharmaceuticals has received final approval from the US FDA for its generic Metformin Hydrochloride tablet salts, a product identified by AND...

Lupin
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Lupin Pharmaceuticals,Inc.

Lupin Pharmaceuticals announced on December 1, 2016, the FDA approval of hydrocodone bitartrate and acetaminophen tablets, an ANDA filing, expanding t...

Aurobindo
FDA Approves CLOZAPINE — Aurobindo Pharma Limited

Aurobindo Pharma Limited announced approval of its Abbreviated New Drug Application for the generic version of Clozapine (ANDA #206433), introducing a...

Sanofi-Aventis
FDA Approves SOLIQUA 100/33 — Sanofi-Aventis U.S. LLC

# FDA Approves Sanofi's SOLIQUA 100/33, a Fixed-Dose Combination Insulin and GLP-1 Receptor Agonist Sanofi-Aventis U.S. LLC received FDA approval for...

Lupin
FDA Approves HYDROCODONE BITARTRATE AND ACETAMINOPHEN — Lupin Pharmaceuticals,Inc.

Lupin Pharmaceuticals has received FDA approval for the generic version of Hydrocodone Bitartrate and Acetaminophen, targeting a product market curren...

PURACAP
FDA Approves ROSUVASTATIN CALCIUM — PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS

Puracap Laboratories LLC doing business as Blu Pharmaceuticals has secured FDA approval for the oral rosuvastatin calcium generic, targeting the high-...

Accord
FDA Approves ROSUVASTATIN — Accord Healthcare Inc.

Accord Healthcare Inc. announced the FDA approval of its rosuvastatin calcium tablets, generating preliminary industry interest as a potential market ...

UNICHEM
FDA Approves SOTALOL — UNICHEM PHARMACEUTICALS (USA), INC.

Unichem Pharmaceuticals (USA), Inc. received the long-awaited FDA approval Monday for its ANDA 207428, providing generic access to oral Sotalol Hydroc...

PHARMOBEDIENT
FDA Approves Unknown Drug — PHARMOBEDIENT

FDA has granted approval for an Abbreviated New Drug Application (ANDA) from PHARMOBEDIENT, marking a pivotal step into the market for the associated ...

Amneal
FDA Approves ITRACONAZOLE — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals received approval for generic itraconazole (ANDA 205080) on September 26, 2016, which expands access to this antifungal oral me...